Protech
  • Members of Rockwell Medical’s (NSD:RMTI) executive management team will be presenting at the 2021 LD Micro Invitational XI on June 10 at 2:30 pm EDT
  • The event will be available live and archived on Rockwell Medical’s website
  • Rockwell Medical is a commercial-stage biopharmaceutical company
  • Rockwell Medical Inc. (NSD:RMTI) is down 2.95 per cent, trading at US$0.891 per share at 10 am ET

Members of Rockwell Medical’s (NSD:RMTI) executive management team will be presenting at the 2021 LD Micro Invitational XI on June 10.

A live webcast of the event will be available on the company’s website.

You may also register as an attendee directly to watch the presentation at https://ldmicrojune2021.mysequire.com .

A replay of the webcast will be archived on the company’s website for 30 days following the presentation.

Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which could lead to transformative treatments for iron deficiency and anemia, reducing healthcare costs and improving patients’ lives.

Rockwell Medical Inc. (NSD:RMTI) is down 2.95 per cent, trading at US$0.891 per share at 10 am ET.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.